

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.43197984 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.43197984 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.43197984 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.43197984 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.43197984 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.43197984 |
| 7 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 6.00596213 |
| 8 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.55465534 |
| 9 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.45616057 |
| 10 | cellular response to zinc ion (GO:0071294) | 5.44227726 |
| 11 | glycosphingolipid catabolic process (GO:0046479) | 5.29210046 |
| 12 | response to peptidoglycan (GO:0032494) | 4.95738156 |
| 13 | respiratory burst (GO:0045730) | 4.93664367 |
| 14 | reactive oxygen species biosynthetic process (GO:1903409) | 4.90160691 |
| 15 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.89975547 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.89214889 |
| 17 | oligosaccharide catabolic process (GO:0009313) | 4.80098386 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.78511403 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.78082892 |
| 20 | glycolipid catabolic process (GO:0019377) | 4.74799143 |
| 21 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.73111495 |
| 22 | cellular extravasation (GO:0045123) | 4.72560022 |
| 23 | regulation of chemokine biosynthetic process (GO:0045073) | 4.51832973 |
| 24 | amino sugar catabolic process (GO:0046348) | 4.48569680 |
| 25 | positive regulation of heat generation (GO:0031652) | 4.44441731 |
| 26 | cellular response to cadmium ion (GO:0071276) | 4.42492710 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 4.38785760 |
| 28 | regulation of podosome assembly (GO:0071801) | 4.38214225 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.34948653 |
| 30 | regulation of fever generation (GO:0031620) | 4.33720357 |
| 31 | ceramide catabolic process (GO:0046514) | 4.22494821 |
| 32 | regulation of macrophage chemotaxis (GO:0010758) | 4.20040182 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18850465 |
| 34 | response to host immune response (GO:0052572) | 4.14540305 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.14540305 |
| 36 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.02924375 |
| 37 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.02410804 |
| 38 | response to thyroid hormone (GO:0097066) | 3.98784471 |
| 39 | superoxide anion generation (GO:0042554) | 3.97275470 |
| 40 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.93857374 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93263381 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.89420831 |
| 43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.89230417 |
| 44 | barbed-end actin filament capping (GO:0051016) | 3.87769516 |
| 45 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.83804155 |
| 46 | surfactant homeostasis (GO:0043129) | 3.83662664 |
| 47 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.81652194 |
| 48 | peptide catabolic process (GO:0043171) | 3.81627467 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.74272170 |
| 50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.74272170 |
| 51 | complement activation, alternative pathway (GO:0006957) | 3.72530455 |
| 52 | response to host (GO:0075136) | 3.71995216 |
| 53 | response to host defenses (GO:0052200) | 3.71995216 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.71995216 |
| 55 | microglial cell activation (GO:0001774) | 3.65110253 |
| 56 | granulocyte activation (GO:0036230) | 3.64074010 |
| 57 | eosinophil chemotaxis (GO:0048245) | 3.58606709 |
| 58 | regulation of cholesterol storage (GO:0010885) | 3.54858489 |
| 59 | positive regulation of bone remodeling (GO:0046852) | 3.52379097 |
| 60 | positive regulation of bone resorption (GO:0045780) | 3.52379097 |
| 61 | leukocyte aggregation (GO:0070486) | 3.50488094 |
| 62 | macrophage activation (GO:0042116) | 3.49570286 |
| 63 | low-density lipoprotein particle clearance (GO:0034383) | 3.44969898 |
| 64 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.43776853 |
| 65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.42303478 |
| 66 | regulation of integrin activation (GO:0033623) | 3.42034815 |
| 67 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.41826952 |
| 68 | positive regulation of interferon-alpha production (GO:0032727) | 3.41090448 |
| 69 | regulation of heat generation (GO:0031650) | 3.40175090 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.37077591 |
| 71 | neutrophil activation (GO:0042119) | 3.36378494 |
| 72 | detection of external biotic stimulus (GO:0098581) | 3.35828494 |
| 73 | negative regulation of lipid storage (GO:0010888) | 3.32261196 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.31858258 |
| 75 | regulation of superoxide anion generation (GO:0032928) | 3.31845343 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 3.30564442 |
| 77 | iron ion import (GO:0097286) | 3.28164721 |
| 78 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.26154044 |
| 79 | eosinophil migration (GO:0072677) | 3.25304210 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.23276504 |
| 81 | membrane lipid catabolic process (GO:0046466) | 3.22857773 |
| 82 | monocyte chemotaxis (GO:0002548) | 3.22378809 |
| 83 | macrophage differentiation (GO:0030225) | 3.21555992 |
| 84 | positive regulation of humoral immune response (GO:0002922) | 3.21074737 |
| 85 | sphingolipid catabolic process (GO:0030149) | 3.20147935 |
| 86 | regulation of interferon-alpha production (GO:0032647) | 3.19503109 |
| 87 | positive regulation of cholesterol efflux (GO:0010875) | 3.17307291 |
| 88 | B cell mediated immunity (GO:0019724) | 3.14892362 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13317873 |
| 90 | negative regulation of cell killing (GO:0031342) | 3.13317873 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.12229552 |
| 92 | protein carboxylation (GO:0018214) | 3.12229552 |
| 93 | phagosome maturation (GO:0090382) | 3.11449700 |
| 94 | T-helper 1 type immune response (GO:0042088) | 3.11138412 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.11131934 |
| 96 | myeloid dendritic cell differentiation (GO:0043011) | 3.10146219 |
| 97 | response to magnesium ion (GO:0032026) | 3.09693715 |
| 98 | N-acetylneuraminate metabolic process (GO:0006054) | 3.09064434 |
| 99 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.08286698 |
| 100 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.07643153 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05996095 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05996095 |
| 103 | cellular response to ethanol (GO:0071361) | 3.05521472 |
| 104 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05433817 |
| 105 | neutrophil chemotaxis (GO:0030593) | 3.04928108 |
| 106 | positive regulation of leukocyte degranulation (GO:0043302) | 3.04815461 |
| 107 | granulocyte chemotaxis (GO:0071621) | 3.04131509 |
| 108 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.02909665 |
| 109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.01276934 |
| 110 | regulation of vitamin metabolic process (GO:0030656) | 2.99365873 |
| 111 | regulation of mast cell degranulation (GO:0043304) | 2.99140623 |
| 112 | acute-phase response (GO:0006953) | 2.98051605 |
| 113 | neutrophil migration (GO:1990266) | 2.96733734 |
| 114 | keratan sulfate catabolic process (GO:0042340) | 2.96270458 |
| 115 | detection of other organism (GO:0098543) | 2.95977776 |
| 116 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.95194448 |
| 117 | regulation of leukocyte degranulation (GO:0043300) | 2.94546386 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.94321036 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.94321036 |
| 120 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94012927 |
| 121 | positive regulation of acute inflammatory response (GO:0002675) | 2.93392685 |
| 122 | regulation of mononuclear cell migration (GO:0071675) | 2.92357432 |
| 123 | * apoptotic cell clearance (GO:0043277) | 2.92148352 |
| 124 | granulocyte migration (GO:0097530) | 2.92088007 |
| 125 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91515525 |
| 126 | positive regulation of tissue remodeling (GO:0034105) | 2.90969521 |
| 127 | detection of biotic stimulus (GO:0009595) | 2.90649805 |
| 128 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90121189 |
| 129 | response to manganese ion (GO:0010042) | 2.88732740 |
| 130 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.87265030 |
| 131 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.86550137 |
| 132 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.86354396 |
| 133 | pinocytosis (GO:0006907) | 2.84192353 |
| 134 | regulation of monocyte differentiation (GO:0045655) | 2.82779562 |
| 135 | intracellular pH reduction (GO:0051452) | 2.82621825 |
| 136 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.81879337 |
| 137 | phospholipid efflux (GO:0033700) | 2.81366294 |
| 138 | detection of bacterium (GO:0016045) | 2.80523224 |
| 139 | cellular response to type I interferon (GO:0071357) | 2.80506085 |
| 140 | type I interferon signaling pathway (GO:0060337) | 2.80506085 |
| 141 | myeloid dendritic cell activation (GO:0001773) | 2.79391816 |
| 142 | lymphocyte chemotaxis (GO:0048247) | 2.78622493 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.78498413 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 2.78431255 |
| 145 | response to type I interferon (GO:0034340) | 2.78331850 |
| 146 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78235635 |
| 147 | chemical homeostasis within a tissue (GO:0048875) | 2.78039530 |
| 148 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77852510 |
| 149 | positive regulation of chemokine production (GO:0032722) | 2.77569911 |
| 150 | positive regulation of antigen processing and presentation (GO:0002579) | 2.76705105 |
| 151 | positive regulation of blood coagulation (GO:0030194) | 2.75094563 |
| 152 | positive regulation of hemostasis (GO:1900048) | 2.75094563 |
| 153 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.74506629 |
| 154 | decidualization (GO:0046697) | 2.74466779 |
| 155 | germinal center formation (GO:0002467) | 2.74305216 |
| 156 | cytokine secretion (GO:0050663) | 2.74232890 |
| 157 | leukocyte cell-cell adhesion (GO:0007159) | 2.72806254 |
| 158 | positive regulation of phagocytosis (GO:0050766) | 2.72783772 |
| 159 | regulation of hypersensitivity (GO:0002883) | 2.71942484 |
| 160 | regulation of antigen processing and presentation (GO:0002577) | 2.71621928 |
| 161 | pH reduction (GO:0045851) | 2.71263369 |
| 162 | glucosamine-containing compound catabolic process (GO:1901072) | 2.70917766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.14930235 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.98307099 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.29132465 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.40480794 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.97187313 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.95810315 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72069696 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40008525 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.37956265 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10124272 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03292653 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01651822 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.85816201 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.71890465 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69642340 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.65460105 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57916395 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51415344 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46753369 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.45108490 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.34749512 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29129897 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25199851 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22287881 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.17080214 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.13801214 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03747990 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89888513 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.85445568 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83232460 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83116185 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80737198 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.76680896 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69232887 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58662209 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53220679 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53008696 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52650891 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52095018 |
| 40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.48951593 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46379742 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46297527 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43877568 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43456228 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42410992 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38477102 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37157408 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36926218 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35765684 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32720580 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32397143 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27028679 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23968628 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.21300517 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19440164 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14473616 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14468408 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14424214 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12750022 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12102028 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.11660400 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10971200 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10447865 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10387522 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09950415 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08906732 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07705015 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07121356 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05424668 |
| 70 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04956235 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04576119 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04504562 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02951896 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02104113 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01514066 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00987672 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00843627 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99712372 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98328029 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98328029 |
| 81 | MYB_26560356_Chip-Seq_TH1_Human | 0.97840457 |
| 82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97233897 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96955763 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95865479 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95395759 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94913372 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94669732 |
| 88 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.93733232 |
| 89 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.93548055 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93212449 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93094344 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92543669 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92435696 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92337815 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91512593 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91201591 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90798973 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90690833 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89163285 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88358410 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87035360 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 0.86665928 |
| 103 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85022792 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80960578 |
| 105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80904997 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80507695 |
| 107 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80464362 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80131954 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80030611 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79827668 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78958834 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78575122 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74713020 |
| 114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72917324 |
| 115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72646626 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71786584 |
| 117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70114828 |
| 118 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68151183 |
| 119 | MAF_26560356_Chip-Seq_TH2_Human | 0.67153261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 3.62590097 |
| 2 | MP0003436_decreased_susceptibility_to | 3.61784064 |
| 3 | MP0003724_increased_susceptibility_to | 3.29356769 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.28858762 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.18692131 |
| 6 | MP0003195_calcinosis | 3.09696775 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.08321183 |
| 8 | MP0003303_peritoneal_inflammation | 2.95599586 |
| 9 | MP0009840_abnormal_foam_cell | 2.92523649 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.87940402 |
| 11 | MP0005083_abnormal_biliary_tract | 2.85072462 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.67960516 |
| 13 | * MP0005025_abnormal_response_to | 2.64387328 |
| 14 | MP0005387_immune_system_phenotype | 2.57752478 |
| 15 | MP0001790_abnormal_immune_system | 2.57752478 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.55927350 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.53324236 |
| 18 | MP0004510_myositis | 2.52653773 |
| 19 | MP0005360_urolithiasis | 2.31585833 |
| 20 | MP0006082_CNS_inflammation | 2.29436296 |
| 21 | MP0009764_decreased_sensitivity_to | 2.17063321 |
| 22 | MP0003075_altered_response_to | 2.15804874 |
| 23 | * MP0002452_abnormal_antigen_presenting | 2.11789189 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 2.09981791 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.09635033 |
| 26 | MP0000685_abnormal_immune_system | 2.02952958 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.02639802 |
| 28 | MP0004947_skin_inflammation | 2.00823670 |
| 29 | * MP0001800_abnormal_humoral_immune | 1.92900518 |
| 30 | * MP0002723_abnormal_immune_serum | 1.92249712 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.90216351 |
| 32 | MP0008469_abnormal_protein_level | 1.89401986 |
| 33 | MP0003329_amyloid_beta_deposits | 1.88231978 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.77739828 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.77265351 |
| 36 | MP0009278_abnormal_bone_marrow | 1.75911088 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.74789225 |
| 38 | MP0002006_tumorigenesis | 1.73399843 |
| 39 | MP0005451_abnormal_body_composition | 1.70260289 |
| 40 | MP0005365_abnormal_bile_salt | 1.70240656 |
| 41 | * MP0001819_abnormal_immune_cell | 1.69344380 |
| 42 | * MP0002420_abnormal_adaptive_immunity | 1.68810130 |
| 43 | * MP0001845_abnormal_inflammatory_respons | 1.68742926 |
| 44 | MP0003828_pulmonary_edema | 1.67302791 |
| 45 | MP0000604_amyloidosis | 1.62200050 |
| 46 | MP0003186_abnormal_redox_activity | 1.52254632 |
| 47 | MP0003646_muscle_fatigue | 1.49166665 |
| 48 | MP0004883_abnormal_blood_vessel | 1.45376125 |
| 49 | MP0002405_respiratory_system_inflammati | 1.42561174 |
| 50 | MP0003448_altered_tumor_morphology | 1.42264514 |
| 51 | MP0005166_decreased_susceptibility_to | 1.41889341 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.40626123 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.34808461 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.34755042 |
| 55 | MP0002332_abnormal_exercise_endurance | 1.33541244 |
| 56 | MP0000343_altered_response_to | 1.31238226 |
| 57 | MP0000858_altered_metastatic_potential | 1.31174193 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.29765473 |
| 59 | MP0005671_abnormal_response_to | 1.27723031 |
| 60 | MP0003252_abnormal_bile_duct | 1.25576689 |
| 61 | MP0000920_abnormal_myelination | 1.25474067 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.21895752 |
| 63 | MP0004130_abnormal_muscle_cell | 1.16138366 |
| 64 | MP0002254_reproductive_system_inflammat | 1.15651483 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.14644525 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.14424739 |
| 67 | MP0003690_abnormal_glial_cell | 1.14078710 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.12474888 |
| 69 | * MP0009763_increased_sensitivity_to | 1.11731816 |
| 70 | MP0008004_abnormal_stomach_pH | 1.11316959 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.10338547 |
| 72 | MP0000716_abnormal_immune_system | 1.10280002 |
| 73 | MP0000609_abnormal_liver_physiology | 1.09992407 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.08242449 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07739228 |
| 76 | MP0001958_emphysema | 1.03926876 |
| 77 | MP0005164_abnormal_response_to | 1.03367141 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.99208223 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.96949496 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.94542743 |
| 81 | MP0003795_abnormal_bone_structure | 0.93894063 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.93101593 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.92901983 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.92901983 |
| 85 | MP0005023_abnormal_wound_healing | 0.92526931 |
| 86 | MP0001853_heart_inflammation | 0.91518229 |
| 87 | MP0005257_abnormal_intraocular_pressure | 0.91501906 |
| 88 | * MP0000689_abnormal_spleen_morphology | 0.89734840 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.89275699 |
| 90 | MP0001851_eye_inflammation | 0.87875844 |
| 91 | MP0002398_abnormal_bone_marrow | 0.87628436 |
| 92 | MP0005535_abnormal_body_temperature | 0.87484591 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87428056 |
| 94 | MP0005390_skeleton_phenotype | 0.86978323 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.86446967 |
| 96 | MP0001542_abnormal_bone_strength | 0.86086930 |
| 97 | MP0002429_abnormal_blood_cell | 0.85765342 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.84760464 |
| 99 | MP0003091_abnormal_cell_migration | 0.84341364 |
| 100 | MP0005647_abnormal_sex_gland | 0.84174348 |
| 101 | MP0004858_abnormal_nervous_system | 0.82695822 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 0.82680778 |
| 103 | MP0002118_abnormal_lipid_homeostasis | 0.82621399 |
| 104 | MP0006054_spinal_hemorrhage | 0.82544066 |
| 105 | MP0003279_aneurysm | 0.82137148 |
| 106 | MP0000569_abnormal_digit_pigmentation | 0.82075105 |
| 107 | MP0008438_abnormal_cutaneous_collagen | 0.80777746 |
| 108 | MP0000249_abnormal_blood_vessel | 0.78469899 |
| 109 | MP0000598_abnormal_liver_morphology | 0.78237101 |
| 110 | MP0005332_abnormal_amino_acid | 0.78114636 |
| 111 | MP0003634_abnormal_glial_cell | 0.77239582 |
| 112 | MP0005165_increased_susceptibility_to | 0.77069112 |
| 113 | MP0008874_decreased_physiological_sensi | 0.75816481 |
| 114 | MP0005310_abnormal_salivary_gland | 0.75553647 |
| 115 | MP0002168_other_aberrant_phenotype | 0.75429503 |
| 116 | MP0002933_joint_inflammation | 0.74940342 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.74431111 |
| 118 | MP0000767_abnormal_smooth_muscle | 0.73154242 |
| 119 | MP0002722_abnormal_immune_system | 0.72760845 |
| 120 | MP0002133_abnormal_respiratory_system | 0.72449097 |
| 121 | MP0005388_respiratory_system_phenotype | 0.72449097 |
| 122 | MP0008873_increased_physiological_sensi | 0.72433509 |
| 123 | MP0008260_abnormal_autophagy | 0.72127407 |
| 124 | MP0001849_ear_inflammation | 0.70770448 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.69322225 |
| 126 | MP0002090_abnormal_vision | 0.66755368 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.66382494 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.63057977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.34972018 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.34972018 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 8.34972018 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.69553137 |
| 5 | Recurrent abscess formation (HP:0002722) | 7.08778740 |
| 6 | Eczematoid dermatitis (HP:0000976) | 6.72429575 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 6.63937153 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.98922341 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 5.58627772 |
| 10 | Glomerulonephritis (HP:0000099) | 4.89489636 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.71368447 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.53387894 |
| 13 | Axonal loss (HP:0003447) | 4.30298769 |
| 14 | Gingivitis (HP:0000230) | 4.28371504 |
| 15 | Joint hemorrhage (HP:0005261) | 4.08984433 |
| 16 | Complement deficiency (HP:0004431) | 3.94063914 |
| 17 | Periodontitis (HP:0000704) | 3.91363882 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.88319415 |
| 19 | Recurrent skin infections (HP:0001581) | 3.87573958 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.65410550 |
| 21 | Mutism (HP:0002300) | 3.63381923 |
| 22 | Abnormality of complement system (HP:0005339) | 3.60272092 |
| 23 | Pustule (HP:0200039) | 3.53167227 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 3.49173175 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39789874 |
| 26 | Deep venous thrombosis (HP:0002625) | 3.38508514 |
| 27 | Thick nail (HP:0001805) | 3.33165587 |
| 28 | Nephritis (HP:0000123) | 3.31189979 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.15220911 |
| 30 | Urticaria (HP:0001025) | 3.09667146 |
| 31 | Gingival bleeding (HP:0000225) | 3.07619846 |
| 32 | Xanthomatosis (HP:0000991) | 3.07537199 |
| 33 | Obstructive lung disease (HP:0006536) | 3.06036536 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.06036536 |
| 35 | Cellulitis (HP:0100658) | 3.04135958 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 3.02298123 |
| 37 | Metaphyseal irregularity (HP:0003025) | 2.96763466 |
| 38 | Menorrhagia (HP:0000132) | 2.96423761 |
| 39 | Retinal atrophy (HP:0001105) | 2.91667403 |
| 40 | Nausea (HP:0002018) | 2.89495019 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.88223091 |
| 42 | Increased IgM level (HP:0003496) | 2.87916425 |
| 43 | Myocardial infarction (HP:0001658) | 2.86227456 |
| 44 | Vasculitis (HP:0002633) | 2.81270595 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.80349006 |
| 46 | Neuronal loss in central nervous system (HP:0002529) | 2.78683419 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.76258346 |
| 48 | Diminished motivation (HP:0000745) | 2.72705341 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70528417 |
| 50 | Amyloidosis (HP:0011034) | 2.69384802 |
| 51 | Peritonitis (HP:0002586) | 2.69306020 |
| 52 | Recurrent viral infections (HP:0004429) | 2.69273740 |
| 53 | Nuclear cataract (HP:0100018) | 2.68590371 |
| 54 | Apathy (HP:0000741) | 2.68211298 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.66235996 |
| 56 | Purpura (HP:0000979) | 2.65058375 |
| 57 | Upper motor neuron abnormality (HP:0002127) | 2.61968627 |
| 58 | Esophageal varix (HP:0002040) | 2.58714193 |
| 59 | Tetraparesis (HP:0002273) | 2.58481860 |
| 60 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.57989959 |
| 61 | Stomatitis (HP:0010280) | 2.57523287 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.51768511 |
| 63 | Osteolytic defects of the hand bones (HP:0009699) | 2.51768511 |
| 64 | Chronic otitis media (HP:0000389) | 2.50257924 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.45647863 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.45594700 |
| 67 | Epistaxis (HP:0000421) | 2.41321873 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.40881859 |
| 69 | Orchitis (HP:0100796) | 2.40312149 |
| 70 | Nasal polyposis (HP:0100582) | 2.38654567 |
| 71 | Abnormality of the periventricular white matter (HP:0002518) | 2.38480932 |
| 72 | Malnutrition (HP:0004395) | 2.37883422 |
| 73 | IgM deficiency (HP:0002850) | 2.36944670 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.35072201 |
| 75 | Gastrointestinal infarctions (HP:0005244) | 2.33849073 |
| 76 | Epidermoid cyst (HP:0200040) | 2.31808436 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28120049 |
| 78 | Prostate neoplasm (HP:0100787) | 2.27226829 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 2.26942583 |
| 80 | Multiple enchondromatosis (HP:0005701) | 2.20527894 |
| 81 | Myositis (HP:0100614) | 2.20483786 |
| 82 | Petechiae (HP:0000967) | 2.19605848 |
| 83 | Conjunctival telangiectasia (HP:0000524) | 2.18628722 |
| 84 | Premature loss of primary teeth (HP:0006323) | 2.17336071 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.16931711 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.15044007 |
| 87 | Agnosia (HP:0010524) | 2.14544028 |
| 88 | Peripheral demyelination (HP:0011096) | 2.14037101 |
| 89 | Hypercholesterolemia (HP:0003124) | 2.13831685 |
| 90 | Osteomyelitis (HP:0002754) | 2.13789185 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.13720846 |
| 92 | Hematochezia (HP:0002573) | 2.12373558 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.12338473 |
| 94 | Inappropriate behavior (HP:0000719) | 2.10851973 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 2.10740393 |
| 96 | Dementia (HP:0000726) | 2.08474827 |
| 97 | Pathologic fracture (HP:0002756) | 2.08206736 |
| 98 | Supranuclear gaze palsy (HP:0000605) | 2.06274105 |
| 99 | Optic neuritis (HP:0100653) | 2.05659248 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 2.05659248 |
| 101 | Neoplasm of head and neck (HP:0012288) | 2.03978983 |
| 102 | Esophageal neoplasm (HP:0100751) | 2.03978983 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00642339 |
| 104 | Disinhibition (HP:0000734) | 1.99895672 |
| 105 | Abnormality of the lumbar spine (HP:0100712) | 1.99870338 |
| 106 | Mucopolysacchariduria (HP:0008155) | 1.99748732 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99748732 |
| 108 | Recurrent pneumonia (HP:0006532) | 1.99540756 |
| 109 | Loss of speech (HP:0002371) | 1.98475745 |
| 110 | Meningitis (HP:0001287) | 1.97814297 |
| 111 | Hyperlipoproteinemia (HP:0010980) | 1.97792576 |
| 112 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97734134 |
| 113 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95656213 |
| 114 | Increased CSF protein (HP:0002922) | 1.95328788 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 1.95012164 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.93617297 |
| 117 | Thoracic kyphosis (HP:0002942) | 1.92100864 |
| 118 | Leukocytosis (HP:0001974) | 1.91390969 |
| 119 | Hemoptysis (HP:0002105) | 1.91362615 |
| 120 | Personality changes (HP:0000751) | 1.90936564 |
| 121 | Joint swelling (HP:0001386) | 1.89755984 |
| 122 | Bone pain (HP:0002653) | 1.88341189 |
| 123 | Mitral stenosis (HP:0001718) | 1.87769469 |
| 124 | Progressive visual loss (HP:0000529) | 1.85225811 |
| 125 | Protuberant abdomen (HP:0001538) | 1.85173693 |
| 126 | Increased serum ferritin (HP:0003281) | 1.84411331 |
| 127 | Pulmonary embolism (HP:0002204) | 1.83978821 |
| 128 | Hemorrhage of the eye (HP:0011885) | 1.82253561 |
| 129 | Restrictive lung disease (HP:0002091) | 1.81806746 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 1.80797463 |
| 131 | Thin bony cortex (HP:0002753) | 1.80698809 |
| 132 | Basal ganglia calcification (HP:0002135) | 1.80684278 |
| 133 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80222765 |
| 134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80222765 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80222765 |
| 136 | Thrombophlebitis (HP:0004418) | 1.79865784 |
| 137 | Skin nodule (HP:0200036) | 1.77423813 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.73968751 |
| 139 | Hyperventilation (HP:0002883) | 1.71972390 |
| 140 | Tubulointerstitial fibrosis (HP:0005576) | 1.71220251 |
| 141 | Polycythemia (HP:0001901) | 1.67922016 |
| 142 | Hypergammaglobulinemia (HP:0010702) | 1.66913545 |
| 143 | Cardiomegaly (HP:0001640) | 1.65488835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.11887188 |
| 2 | MAP3K14 | 3.88150609 |
| 3 | ERN1 | 3.37319070 |
| 4 | TYK2 | 2.95702444 |
| 5 | NME2 | 2.95569588 |
| 6 | BLK | 2.85320960 |
| 7 | MAP4K1 | 2.81954414 |
| 8 | FGR | 2.78164155 |
| 9 | TBK1 | 2.60774805 |
| 10 | CSK | 2.57798675 |
| 11 | JAK3 | 2.54132708 |
| 12 | RIPK1 | 2.52112214 |
| 13 | IRAK3 | 2.48873637 |
| 14 | MST1R | 2.39613966 |
| 15 | PBK | 2.02122015 |
| 16 | IKBKE | 1.97765626 |
| 17 | IRAK4 | 1.97402541 |
| 18 | MAP3K3 | 1.89596708 |
| 19 | DDR2 | 1.88824873 |
| 20 | MAP3K13 | 1.86829237 |
| 21 | CAMK1D | 1.80096230 |
| 22 | JAK1 | 1.79347220 |
| 23 | PRPF4B | 1.77523284 |
| 24 | MAP2K3 | 1.74818577 |
| 25 | TXK | 1.73771106 |
| 26 | MAP3K11 | 1.67487875 |
| 27 | CSF1R | 1.63415322 |
| 28 | FGFR4 | 1.53244135 |
| 29 | TAOK3 | 1.52663134 |
| 30 | TAOK2 | 1.49492768 |
| 31 | DAPK2 | 1.48357813 |
| 32 | CDC42BPA | 1.48319852 |
| 33 | IKBKB | 1.46488926 |
| 34 | KIT | 1.32603606 |
| 35 | ZAP70 | 1.31539685 |
| 36 | HCK | 1.31003286 |
| 37 | FES | 1.30891888 |
| 38 | JAK2 | 1.30305703 |
| 39 | CAMKK2 | 1.29359570 |
| 40 | STK10 | 1.25922784 |
| 41 | TAOK1 | 1.25064039 |
| 42 | BMX | 1.21087286 |
| 43 | ACVR1B | 1.17543897 |
| 44 | LYN | 1.15153627 |
| 45 | SYK | 1.12393102 |
| 46 | NEK9 | 1.11790867 |
| 47 | CAMK1G | 1.10781441 |
| 48 | MET | 1.06539980 |
| 49 | ABL2 | 1.03539020 |
| 50 | MATK | 1.02349129 |
| 51 | TESK1 | 0.98871309 |
| 52 | LCK | 0.97368733 |
| 53 | YES1 | 0.93744477 |
| 54 | TESK2 | 0.93312102 |
| 55 | EGFR | 0.93241741 |
| 56 | TTN | 0.92436440 |
| 57 | TGFBR2 | 0.91292415 |
| 58 | RPS6KA2 | 0.91121680 |
| 59 | CLK1 | 0.87672846 |
| 60 | CHUK | 0.84531504 |
| 61 | KSR2 | 0.82692834 |
| 62 | ERBB4 | 0.82342762 |
| 63 | PAK4 | 0.81993102 |
| 64 | ADRBK2 | 0.81034324 |
| 65 | DMPK | 0.79779366 |
| 66 | BMPR2 | 0.79297575 |
| 67 | LIMK1 | 0.78524721 |
| 68 | TGFBR1 | 0.77655180 |
| 69 | MAPK15 | 0.77300566 |
| 70 | EPHB1 | 0.77137800 |
| 71 | PDPK1 | 0.75575457 |
| 72 | MAP3K6 | 0.75088492 |
| 73 | NTRK1 | 0.72636437 |
| 74 | FYN | 0.72618857 |
| 75 | EPHA3 | 0.72365795 |
| 76 | PRKCD | 0.70762883 |
| 77 | MAPK12 | 0.70444284 |
| 78 | FLT3 | 0.70411050 |
| 79 | ADRBK1 | 0.67783695 |
| 80 | MAP2K6 | 0.66000242 |
| 81 | TRIB3 | 0.63916794 |
| 82 | PTK6 | 0.63785258 |
| 83 | EPHB2 | 0.63075487 |
| 84 | PDK1 | 0.62810091 |
| 85 | FGFR3 | 0.62708202 |
| 86 | LRRK2 | 0.62591088 |
| 87 | PRKCH | 0.62189682 |
| 88 | KDR | 0.61995557 |
| 89 | MARK3 | 0.60774433 |
| 90 | CDK4 | 0.60265199 |
| 91 | PIM2 | 0.60088815 |
| 92 | DAPK3 | 0.59100153 |
| 93 | RPS6KA4 | 0.57722981 |
| 94 | TNK2 | 0.57472097 |
| 95 | EIF2AK2 | 0.56902692 |
| 96 | MAPK7 | 0.55636732 |
| 97 | BTK | 0.54061837 |
| 98 | MARK2 | 0.53225123 |
| 99 | IGF1R | 0.52919705 |
| 100 | ABL1 | 0.52721654 |
| 101 | IRAK2 | 0.52285205 |
| 102 | INSR | 0.50828269 |
| 103 | MOS | 0.50060078 |
| 104 | FRK | 0.48806722 |
| 105 | IRAK1 | 0.48138684 |
| 106 | PRKCQ | 0.46954607 |
| 107 | GRK6 | 0.45575594 |
| 108 | MAP3K5 | 0.45172010 |
| 109 | STK3 | 0.44501125 |
| 110 | ARAF | 0.44287980 |
| 111 | PKN2 | 0.43180415 |
| 112 | GRK5 | 0.41523383 |
| 113 | SGK3 | 0.41176513 |
| 114 | GRK7 | 0.40184889 |
| 115 | RPS6KA6 | 0.39385804 |
| 116 | DAPK1 | 0.38033242 |
| 117 | LATS2 | 0.37941021 |
| 118 | RPS6KL1 | 0.37249704 |
| 119 | RPS6KC1 | 0.37249704 |
| 120 | PDGFRB | 0.37096981 |
| 121 | PDK2 | 0.36814529 |
| 122 | MAP3K8 | 0.35675971 |
| 123 | CAMKK1 | 0.33729254 |
| 124 | PIM1 | 0.33705337 |
| 125 | PRKACG | 0.33489709 |
| 126 | ITK | 0.33105911 |
| 127 | MAPK4 | 0.32853215 |
| 128 | PIK3CG | 0.31763967 |
| 129 | GSK3A | 0.31450989 |
| 130 | MAP3K1 | 0.31376665 |
| 131 | MAPK11 | 0.30645289 |
| 132 | EIF2AK1 | 0.30014347 |
| 133 | SIK1 | 0.29976648 |
| 134 | SRC | 0.29678480 |
| 135 | BCKDK | 0.29385967 |
| 136 | ALK | 0.27012950 |
| 137 | MAP3K10 | 0.26928671 |
| 138 | STK4 | 0.25952923 |
| 139 | PRKG2 | 0.25928853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.64884973 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20953829 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.17559975 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.89163987 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.62921991 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60747228 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.50627174 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23226416 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15121506 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.15029759 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04408398 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02929122 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.98319654 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96158461 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.87958572 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77248436 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73755606 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70256643 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69666890 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.64843609 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60274307 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54771947 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54235340 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48829503 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.47665102 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.46323271 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46201666 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45277828 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.43512527 |
| 30 | * Phagosome_Homo sapiens_hsa04145 | 1.41483498 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36078729 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35938974 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33748915 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.31925459 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.31268440 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24704204 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.24003444 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20125745 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19714008 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.17958767 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11825429 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08977737 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07175181 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03082837 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02771554 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 1.02609106 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02404924 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.00274255 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99782964 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99735602 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95525492 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91870551 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91031550 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88621619 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.88167821 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86785369 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82632145 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.82454939 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82230513 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80661026 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.80503123 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.80383553 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79704659 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.78935577 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78521032 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75017899 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73750642 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.73214104 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72573738 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72322160 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67536101 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65993671 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62996424 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59502799 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58656449 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57409053 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57161387 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56139187 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.54948331 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54670197 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.54579053 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54176905 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.53698124 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53017175 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49581565 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46019125 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45522626 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.43021746 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42150950 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42076152 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40514950 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39305601 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38921489 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34512942 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33947689 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32688056 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32143406 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32119373 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31893466 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.30863281 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30693530 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30001065 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29982414 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29922795 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29070412 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28715541 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27272558 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26116570 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25748507 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25298654 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.25142267 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24937353 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24303922 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.23511874 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22621609 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21463787 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20604791 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19518271 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19173354 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18902189 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17172295 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12958545 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12195135 |

